Sleep Difficulties and Medications in Children With Autism Spectrum Disorders: A Registry Study

Beth A Malow1, Terry Katz2, Ann M Reynolds2

  • 1Sleep Disorders Division, Department of Neurology, Vanderbilt University School of Medicine, Nashville, Tennessee; beth.malow@vanderbilt.edu.

Pediatrics
|February 25, 2016
PubMed

Insights

Sleep difficulties affect 71% of children with autism spectrum disorder (ASD), impacting behavior. Medications are common but linked to poorer outcomes, highlighting the need for better interventions.

Area of Science:

  • Pediatric Sleep Medicine
  • Autism Spectrum Disorder Research
  • Clinical Psychology

Background:

  • Sleep difficulties are prevalent in children with autism spectrum disorder (ASD).
  • These sleep issues significantly impact children's daytime behavior and quality of life.
  • Understanding sleep patterns and medication use in ASD is crucial for effective management.

Purpose of the Study:

  • To determine the prevalence of sleep difficulties in children with ASD.
  • To analyze patterns of sleep medication use in this population.
  • To investigate the relationship between sleep problems, medication, and daytime behavior.

Main Methods:

  • Analysis of data from 1518 children aged 4-10 years in the Autism Speaks Autism Treatment Network Registry.
  • Utilized parent-completed questionnaires (Children's Sleep Habits Questionnaire) and clinician-completed forms.
  • Examined sleep diagnoses and prescribed sleep medications.

Main Results:

  • 71% of children with ASD reported clinically significant sleep problems.
  • Sleep diagnoses were less frequent (30%) than reported sleep difficulties.
  • Medications were used by 46% of children with a sleep diagnosis, with melatonin being most common. Children on sleep medication showed worse daytime behavior and quality of life.

Conclusions:

  • Parental concerns about sleep in ASD may be underreported in clinical settings, necessitating improved screening.
  • Current sleep medications in children with ASD are associated with adverse effects and poorer outcomes.
  • There is a critical need for evidence-based sleep interventions for children with autism spectrum disorder.
Abstract

Related Concept Videos

Autism Spectrum Disorder01:19

Autism Spectrum Disorder

Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
1.7K
Nightmares and Night Terrors01:18

Nightmares and Night Terrors

Nightmares and night terrors represent two distinct types of sleep disturbances that differ in timing, characteristics, and the sleeper's recall of the event. Nightmares are vivid, disturbing dreams that usually awaken the sleeper from REM sleep, a stage of sleep where brain activity is high, and dreams are most frequent. Upon awakening, individuals often have detailed recollections of their nightmares, which can include themes of threats to survival, security, or self-esteem.
Nightmares...
767
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
805
Management of Insomnia01:19

Management of Insomnia

The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
773
Sleepwalking and Sleep Talking01:17

Sleepwalking and Sleep Talking

Somnambulism, commonly known as sleepwalking, involves individuals engaging in activities ranging from simple walking to more complex behaviors such as driving. Sleepwalking typically occurs during the slow-wave sleep stages 3 and 4 early in the night when the person is not dreaming, contradicting the myth that sleepwalkers are acting out their dreams.
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
1.4K
Insomnia01:27

Insomnia

Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
572